[Translation] A clinical trial to evaluate the batch-to-batch consistency and safety of three batches of group A and group C meningococcal polysaccharide conjugate vaccines in healthy infants aged 6-11 months

评价成都欧林生物科技股份有限公司生产的三个批次A群C群脑膜炎球菌多糖结合疫苗在6-11月龄婴幼儿中接种的免疫原性的批间一致性和安全性。

[Translation]

To evaluate the batch-to-batch consistency and safety of immunogenicity of three batches of group A and group C meningococcal polysaccharide conjugate vaccines produced by Chengdu Olin Biotechnology Co., Ltd. in infants aged 6-11 months.

Start Date06 Dec 2023

Sponsor / Collaborator

Chengdu Olymvax Biopharmaceuticals, Inc.

CTR20232302

/ Active, not recruitingPhase 4

A群C群脑膜炎球菌多糖结合疫苗在12-23月龄幼儿中不同免疫程序探索的临床试验

[Translation] A clinical trial exploring different immunization schedules for group A and group C meningococcal polysaccharide conjugate vaccines in children aged 12-23 months

探索成都欧林生物科技股份有限公司生产的A群C群脑膜炎球菌多糖结合疫苗在12 -23月龄幼儿中的免疫程序。

[Translation]

To explore the immunization schedule of group A and group C meningococcal polysaccharide conjugate vaccine produced by Chengdu Olin Biotechnology Co., Ltd. in children aged 12-23 months.

Start Date10 Aug 2023

Sponsor / Collaborator

Chengdu Olymvax Biopharmaceuticals, Inc.

CTR20160001

/ CompletedPhase 3

对中国3月龄-5周岁健康婴幼儿进行A群C群脑膜炎球菌结合疫苗单中心、随机、盲态、非劣效设计III期临床试验

[Translation] A single-center, randomized, blinded, non-inferiority phase III clinical trial of group A and group C meningococcal conjugate vaccine in healthy infants aged 3 months to 5 years in China

本研究为单中心、随机盲态、阳性对照、非劣效设计的III期临床试验，用于评价成都欧林生物科技股份有限公司研制的A群C群脑膜炎球菌结合疫苗在中国3月龄-5周岁健康婴幼儿中接种的免疫原性和安全性。

[Translation]

This study is a single-center, randomized, blinded, positive-controlled, non-inferiority designed Phase III clinical trial to evaluate the immunogenicity and safety of group A and group C meningococcal conjugate vaccine developed by Chengdu Olin Biotechnology Co., Ltd. in healthy infants and young children aged 3 months to 5 years in China.

Start Date16 May 2016

Sponsor / Collaborator

Chengdu Olymvax Biopharmaceuticals, Inc.

100 Clinical Results associated with A/C meningococcal conjugate vaccine(Olymvax Biopharmaceuticals)

100 Translational Medicine associated with A/C meningococcal conjugate vaccine(Olymvax Biopharmaceuticals)

100 Patents (Medical) associated with A/C meningococcal conjugate vaccine(Olymvax Biopharmaceuticals)

100 Deals associated with A/C meningococcal conjugate vaccine(Olymvax Biopharmaceuticals)

External Link

KEGG	Wiki	ATC	Drug Bank
-	-	J07AH	-

R&D Status

10 top approved records.

to view more data

Indication	Country/Location	Organization	Date
Meningitis	China	Chengdu Olymvax Biopharmaceuticals, Inc.	30 Sep 2020

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis